Home NCLi

NCLi

In operation
-
Full-Chain CDMO Service Provider for Cell and Gene Therapy
Basic
Enterprise Profile

Basic Information

NCLi provides end-to-end CDMO services in the cell and gene therapy field, including two core segments: CDO (Contract Development Services): process development for cell and gene therapies, and CMO (Contract Manufacturing Services): manufacturing services for cell and gene therapies. The company owns one of the largest CDMO production facilities in Japan and has established an exclusive partnership with Lonza, a global CDMO leader, to jointly advance the manufacturing business of cell and gene therapies in Japan. NCLi is a wholly-owned subsidiary of Nikon.
Nikon CeLL innovation Co., Ltd.
Tokyo,Tokyo,Japan
unclear
May 07, 2015
--

Enterprise Profile

Industrial Sector
New Drug Development Registration and Certification Services Biological Drug Production Chief Medical Officer CDMO
Technology
Gene Technology Cell Technology
Concept
Therapeutic Products
Application Scenarios
Biological Products Cell and Gene Therapy